Moreover, several antineoplastic therapies such as anthracyclines and HER2-targeted therapies (used more commonly in females to treat breast cancer), and radiation therapy are potentially cardiotoxic, adding to the likelihood of developing HF. This evidence concerns the gene ERBB2 and breast cancer.